US2018327801A1PendingUtilityA1

METHOD FOR PREPARING RECOMBINANT PROTEINS THROUGH REDUCTION OF rnpA GENE EXPRESSION

Assignee: KOREA ADVANCED INST SCI & TECHPriority: Dec 9, 2014Filed: Jul 5, 2018Published: Nov 15, 2018
Est. expiryDec 9, 2034(~8.3 yrs left)· nominal 20-yr term from priority
C12P 21/00C12Y 301/26005C12N 15/1137C12N 2310/14C12N 2330/50C12P 21/02C12N 9/16C07K 14/43518C12N 15/63
58
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A method is described for improving the production of a difficult-to-express recombinant protein in a recombinant microorganism, and more particularly a method for improving the production of a difficult-to-express recombinant protein by use of a recombinant microorganism into which a gene encoding a target protein and an sRNA against a gene encoding ribonuclease P are introduced. By the disclosed method, expressions of a large recombinant protein, a difficult-to-express protein and a useful protein can be dramatically increased by reducing expression of the rnpA gene.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A method for producing a target protein, comprising the steps of:
 producing the target protein by culturing a recombinant microorganism into which a gene encoding the target protein is introduced; and   recovering the produced target protein,   wherein a substance of reducing expression of ribonuclease P is added in the culture to increase expression of the target protein.   
     
     
         2 . The method of  claim 1 , wherein the target protein is a difficult-to-express protein or a protein having a molecular weight of 50 kDa or more. 
     
     
         3 . The method of  claim 1 , wherein the target protein is a silk protein, antibody, cytochrome, enzyme, or sortase A. 
     
     
         4 . The method of  claim 1 , wherein said substance is an sRNA. 
     
     
         5 . The method of  claim 1 , wherein said sRNA is an sRNA against an rnpA gene. 
     
     
         6 . The method of  claim 1 , wherein said sRNA has a nucleotide sequence of any one of SEQ ID NOS: 1 to 3.

Join the waitlist — get patent alerts

Track US2018327801A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.